Objective To introduce the research and market development of enalapril as an angiotensin1-converting enzyme inhibitor (ACEI) for treating hypertension.
目的介绍抗高血压药血管紧张素转化酶抑制剂（ACEI）依那普利的研发及市场情况。
2
Angiotensin - (1-7) is a small peptide that binds to proteins on the surface of cells and prevents cell growth - but only if the cell is actively growing when the binding occurs.
Conclusions Early blockade of the renin-angiotensin system in patients with type 1 diabetes did not slow nephropathy progression but slowed the progression of retinopathy.